Skip to main content

9 Result(s)

within Jayastu Senapati Remove this filter

and

  1. No Access

    Article

    An Update on the Management of Advanced Phase Chronic Myeloid Leukemia

    While most patients with chronic myeloid leukemia (CML) present in a chronic phase and are expected to have a normal life expectancy, some patients present with or progress to a more aggressive accelerated pha...

    Nicholas J. Short, Jayastu Senapati… in Current Hematologic Malignancy Reports (2023)

  2. Article

    Open Access

    A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis

    In TP53 wild-type acute myeloid leukemia (AML), inhibition of MDM2 can enhance p53 protein expression and potentiate leukemic cell apoptosis. MDM2 inhibitor (MDM2i) monotherapy in AML has shown modest responses i...

    Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A. Abbas… in Blood Cancer Journal (2023)

    Download PDF (1772 KB) View Article

  3. No Access

    Article

    Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations

    Samuel Urrutia, Ziyi Li, Emmanuel Almanza, Alex Bataller… in Leukemia (2023)

  4. Article

    Open Access

    Management of chronic myeloid leukemia in 2023 – common ground and common sense

    With the improving knowledge of CML and its management, the goals of therapy need to be revisited to ensure an optimal use of the BCR::ABL1 TKIs in the frontline and later-line therapy of CML. In the frontline...

    Jayastu Senapati, Koji Sasaki, Ghayas C. Issa, Jeffrey H. Lipton… in Blood Cancer Journal (2023)

    Download PDF (802 KB) View Article

  5. No Access

    Article

    Pathogenesis and management of accelerated and blast phases of chronic myeloid leukemia

    The treatment of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKIs) has been a model for cancer therapy development. Though most patients with CML have a normal quality and duration of life ...

    Jayastu Senapati, Elias Jabbour, Hagop Kantarjian, Nicholas J. Short in Leukemia (2023)

  6. No Access

    Article

    Disease Status at Transplant has a Significant Impact on Outcomes of Autologous Transplantation (ASCT) in Patients with Hodgkin Lymphoma—A Single Center Experience

    High dose chemotherapy followed by autologous stem cell transplantation is the treatment of choice for relapsed Hodgkin lymphoma (HL). We analyzed 100 consecutive patients who underwent ASCT at our center betw...

    Jayastu Senapati, Anup J. Devasia… in Indian Journal of Hematology and Blood Tra… (2022)

  7. Article

    Tele-Medicine Services in Hematological Practice During Covid Pandemic: Its Feasibility and Difficulties

    In COVID 19 pandemic, delivery and access of health care services have become challenging. Telemedicine services can be considered for management of patients with hematological diseases. This study included al...

    Pradeep Kumar, Mukul Aggarwal, Rishi Dhawan… in Indian Journal of Hematology and Blood Tra… (2021)

    Download PDF (146 KB) View Article

  8. No Access

    Article

    Diffuse Large B Cell Lymphoma in Wiskott-Aldrich Syndrome: A Case Report and Review of Literature

    Wiskott-Aldrich syndrome (WAS) is an X linked rare primary immunodeficiency syndrome with an increased propensity for infection, autoimmunity and malignancy. Here we report a male child, who was diagnosed with...

    Jayastu Senapati, Anup J. Devasia… in Indian Journal of Hematology and Blood Tra… (2014)

  9. No Access

    Article

    Asymptomatic gastrosplenic fistula in a patient with marginal zonal lymphoma transformed to diffuse large B cell lymphoma—a case report and review of literature

    Jayastu Senapati, Anup J. Devasia, Sniya Sudhakar, Auro Viswabandya in Annals of Hematology (2014)